![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Laurus Labs Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Gemcitabine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-026 - Rev 02
This Chemical Type CEP, issued on January 24, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2306 associated with this CEP further emphasizes